VDRM most recent update stating they are in the final stages for FDA approval (Nigeria)
VDRM experiencing significant month to month growth in sales.
Registering of Vitastem for medical insurance coverage is underway and expected to have final approval for insurance payments and reimbursements for January 2019.
Additionally, the Company is announcing they are close to finalizing a sales agreement for 10,000 units per month of Vitastem with a distributor in Vietnam.
Also, ViaDerma is in early stage discussions to have their product, Viastem sold in Direct Response ads on TV, and distributed through a network of 600 Skilled Nursing Facilities in California and 5000 hospitals in the east coast.
ViaDerma President, Dr. Christopher Otiko said, "As I pointed out in my recent letter to shareholders, we are very excited about our future and our current trajectory. In spite of some minor delays, we remain optimistic this will be a very strong year for ViaDerma."
News 
Market Data 
Discover 
